drugset / Trial / NCT06209047

Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis

NCT06209047

Phase 4 Recruiting 315 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized single-center trial evaluating whether bronchoscopic instillation of levofloxacin or gentamicin improves outcomes compared to a sham bronchoscopic procedure in adult ICU patients with non-cystic fibrosis bronchiectasis requiring invasive mechanical ventilation. The primary outcome is a ranked composite of in-hospital mortality and time to ventilator liberation. Safety and procedural adverse events are closely monitored.

Timeline

Start
2023-10-15
Primary completion
2026-05-15
Completion
2027-02-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gentamicin Small molecule 80 mg Other
Subject Levofloxacin Small molecule 480 mg Other
Subject Levofloxacin Small molecule 500 mg Other
Background Budesonide Small molecule 0.5 mg Other

Indications